Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
132
datasets available to search
ShareScore release 0.9.0
Dataset results
132 results for “GDC”
A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00854152. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
ClinicalTrials.gov study NCT04449874. IPD Sharing: NO. Countries: 17. Publications: 3.
A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma
ClinicalTrials.gov study NCT01564251. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
ClinicalTrials.gov study NCT02558816. IPD Sharing: NO. Countries: 2. Publications: 2.
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT03332797. IPD Sharing: NO. Countries: 5. Publications: 2.
A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT02471846. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
ClinicalTrials.gov study NCT01547546. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
ClinicalTrials.gov study NCT00968981. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00854126. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors
ClinicalTrials.gov study NCT01090960. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Ca
ClinicalTrials.gov study NCT00960960. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT01362374. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT02203773. IPD Sharing: NO. Countries: 4. Publications: 9.
A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
ClinicalTrials.gov study NCT01160250. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
ClinicalTrials.gov study NCT01442090. IPD Sharing: Not stated. Countries: 5. Publications: 1.
TCGA breast cancer (BRCA) mRNA-Seq data from GDC
<p>TCGA BRCA mRNA-seq data used in <a href="https://ocbe-uio.github.io/survomics/survomics.html">https://ocbe-uio.github.io/survomics/survomics.html</a></p>
GDC database
<p>GDC Database</p>
Degradation of Ni-YSZ and Ni-GDC fuel cells after 1000 h operation: Analysis of different overpotential contributions according to electrochemical and microstructural characterization
<p>Datasets from the paper:</p> <p>"Degradation of Ni-YSZ and Ni-GDC fuel cells after 1000 h operation: Analysis of different overpotential contributions according to electrochemical and microstructural characterization". E3S Web of Conferences <strong>334</strong>, 04011 (2022).</p> <p>The activity was carried out within the framework of the European Project AD ASTRA. This project has received funding from the Fuel Cells and Hydrogen 2 Joint Undertaking under <strong>Grant Agreement No 825027</strong>. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and Hydrogen Europe.</p>
Dataset I related to publication: Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 revealed by all atom molecular dynamics simulations
<p>Dataset related to publication:<em> </em></p> <p><em>Leini, R., Kapp, J., Kopra, K. et al. Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 revealed by all atom molecular dynamics simulations. Sci Rep <strong>15</strong>, 24843 (2025). https://doi.org/10.1038/s41598-025-07532-2</em></p> <ul> <li>.zip-files contain the raw Desmond trajectories of individual replica simulations of GDC-6036.</li> <li>WaterMap-output file for the representative conformation of GDC-6036.</li> </ul>
Dataset II related to publication: Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 revealed by all atom molecular dynamics simulations
<p>Dataset related to publication:<em> </em></p> <p>Leini, R., Kapp, J., Kopra, K. <em>et al.</em> Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 revealed by all atom molecular dynamics simulations. <em>Sci Rep</em> <strong>15</strong>, 24843 (2025). https://doi.org/10.1038/s41598-025-07532-2</p> <ul> <li>.zip-files contain the raw Desmond trajectories of individual replica simulations of LY3537982.</li> <li>WaterMap-output file for the representative conformation of LY3537982</li> </ul>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.